A selection of Mr. Green’s recent representations include:
- Represented AbsCi in its acquisition of Totient.
- Represented Eventide Asset Management in its Series D investment in Turnstone Biologics.
- Represented RTW Investments in a preferred stock investment in Alcyone Therapeutics.
- Represented Sword Health in its Series C financing.
- Represented Venrock in its investment in Element Bio’s Series C financing.
- Represented Vedanta in its Series D financing.
- Represented Kriya Therapeutics in its Series B financing.